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Background: A strategy for reducing mental illness-related stigma in health-profession students is to include
contact-based sessions in their educational curricula. In such sessions students are able to interact socially with a
person that has a mental illness. We sought to evaluate the effectiveness of this strategy in a multi-centre study of
pharmacy students.
Methods: The study was a randomized controlled trial conducted at three sites. Because it was necessary that all
students receive the contact-based sessions, the students were randomized either to an early or late intervention,
with the late intervention group not having participated in the contact-based education at the time when the
primary outcome was assessed. The primary outcome, stigma, was assessed using an attitudes scale called the
Opening Minds Survey for Health Care Providers (OMS-HC).
Results: We initially confirmed that outcomes were homogeneous across study centres, centre by group
interaction, p = 0.76. The results were pooled across the three study centres. A significant reduction in stigma was
observed in association with the contact-based sessions (mean change 4.3 versus 1.5, t=2.1, p=0.04). The effect size
(Cohen’s d) was 0.45. A similar reduction was seen in the control group when they later received the intervention.
Conclusions: Contact-based education is an effective method of reducing stigma during pharmacy education.
These results add to a growing literature confirming the effectiveness of contact-based strategies for stigma
reduction in health profession trainees.Background
Although there is no generally accepted ‘unitary theory’
of stigma [1], it can be defined as ‘an attribute that is
deeply discrediting and that reduces the bearer from a
whole and usual person to a tainted, discounted one’ [2].
A sparsely studied yet significant area of concern is
stigma and discrimination against people with mental ill-
ness by health care providers. Attitudes held by health
care providers can have a negative impact on patient
quality of life [3].
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reproduction in any medium, provided the orrelationship and are likely to compound a mentally ill
person’s feelings of rejection and isolation. A primary
goal of the pharmacist is to identify and resolve patient-
specific medication-related issues, ensuring treatment
choices are accepted, needed, safe and effective [4]. To
achieve this goal, the pharmacist must gather informa-
tion from the patient about health and medication con-
cerns, other mental or physical health problems, use of
other medications or substances, and so on. Pharmacist
attitudes and communication styles (verbal and non-verbal)
are pivotal in establishing the strong therapeutic rapport
required to achieve these goals [4]. Involvement of
pharmacists in mental health care can improve outcomes,
prescribing practices, patient satisfaction, and resource
use [5].
The stigmatization of people with mental illness by
pharmacists has the same negative effects propagated byLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pharmacists may lead to counterproductive communica-
tions and failure to meet the health care needs of the in-
dividual [7]. For example, a stigmatizing pharmacist may
be less likely to inform a young woman who self-selects
St John’s wort for depression that the herbal medication
can reduce the effectiveness of her oral contraceptives
[8]. The same pharmacist may appear to be less ap-
proachable by a craft worker who is frustrated by fine
hand tremor caused by lithium and is considering stop-
ping it.
A recent study by Black et al. [9] assessed patient pre-
ferences, satisfaction and perceived stigma by commu-
nity pharmacists. Of concern is that 26% indicated they
did not feel comfortable speaking to a pharmacist about
their mental health medication. This suggests that
stigma may play a significant role in preventing patients
from achieving the maximum benefit from professional
pharmacy services.
Phokeo et al. [7] examined community pharmacists’
attitudes toward and professional interactions with users
of psychiatric medication. A greater proportion of phar-
macists expressed discomfort discussing symptoms and
medications with patients who had mental illness
(36%) compared to patients with cardiovascular disease
(6%). Scheerder et al. [10] reported discrepancies in
pharmacists’ practice involving depressed patients when
compared to other conditions. For example, 70% of phar-
macists reported maintaining a trusting relationship with
most or all patients with other conditions but only
32% reported this for depressed patients. In a survey
of Belgian pharmacists, Liekens et al. [11] found that
even though pharmacists held generally positive attitudes
toward providing care for people with depression, they
also reported delivering less care. Based on data collected
in a mail survey, Rickles et al. [12] reported that pharma-
cists had a lower willingness to provide services for mental
illness versus asthma.
Negative attitudes among pharmacy students were
reported in a series of international surveys, although
specific attitudes were found to vary considerably by
country [13].
A study by Bell et al., [14] compared the attitudes of
third year pharmacy students with those of pharmacy
graduates. The third year students had not yet received
any mental health lectures or tutorials as part of their
curriculum whereas the graduates had completed lec-
tures and tutorials as well as six months of supervised
clinical practice. Stigmatizing attitudes towards people
with mental illness were documented in both groups
and there was no statistical difference noted between
groups. These results suggest that traditional forms of
pharmacy education do not reduce stigma. Consistent
with this, Jermain and Crismon [15] reported thatpsychiatric rotations did not improve social distance rat-
ings among pharmacy students (a preference for greater
social distance is generally viewed as a component of
stigmatization). Another study that included an assess-
ment of social distance reported improved ratings in 60
pharmacy students that participated in a mental health
first aid course, compared to 212 students that either
did not apply for the course or were not randomly
selected for it.
Involvement of consumer-educators in pharmacy edu-
cation has been viewed as a possible means to diminish
stigma. A non-randomized study by Bell et al. [16] com-
pared the impact of a tutorial session involving a
pharmacist instructor, small group work, case studies
and role playing when the tutorial was delivered with
and without participation of a consumer educator. After
the intervention, students in the consumer-educator
group showed more consistent improvement on items
indicative of social distance, diminished negative atti-
tudes and increased positive attitudes towards mental
illness.
At least three Canadian pharmacy faculties have incor-
porated measures to address stigma into their curricula.
These schools have made use of contact-based learning
interventions for several years. Contact-based education
uses social contact as a way to improve relations among
groups that are experiencing stigma and discrimination
[17,18]. Stigma is reduced by providing an opportunity
for interpersonal contact between people who have a
mental illness and audiences who may be stigmatizing
towards them. A key ingredient of contact-based educa-
tion is the delivery of testimonies by service users [19].
The success of contact-based education is generally sup-
ported in the literature, however, the type of contact has
to be appropriate [17,18]. That is, the contact must be
with people who live with a mental illness but are recov-
ered or in recovery.
The purpose of this study was to evaluate the impact
of contact-based education on pharmacy students’ atti-
tudes towards people with mental illness. It was
hypothesized that contact-based sessions would diminish
stigma towards individuals with mental illness.
Methods
Study design
This was a randomized trial that involved 3rd and 4th
year pharmacy students enrolled at three Canadian
undergraduate pharmacy programs (Dalhousie Univer-
sity, Memorial University of Newfoundland, and the
University of Saskatchewan). For several years, each of
these institutions has offered a contact-based session
(see below for a description) ranging from 60 to 90 min-
utes as part of their mental health curriculum. In order
to differentiate whether this specific aspect of the
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were randomized (1:1) to either receive the intervention,
or not, early in their mental health unit. Those not re-
ceiving the intervention early participated at a later time,
near the end of the unit, approximately 2–3 weeks later.
Stigma was assessed at three time points: (1) prior to
any students receiving the intervention, (2) when the
early group had attended the session and the late group
had not, and (3) after both groups had received the
intervention. The primary analysis was assessed at the
second time point and evaluated change from the base-
line assessment to that time point.
For operational reasons, the T3 assessment occurred
approximately one month after the T2 assessment, such
that there was a longer duration of time between the
intervention and post-intervention assessment in the late
group. See Figure 1 for a schematic representation of the
study design. Data for the second assessment was col-
lected 2–3 days after the session at Dalhousie, where the
students deposited their questionnaire into a box (pre-
serving their anonymity). At the other schools an on-
line system was used to collect the data, generally within
a similar time frame. Participation was highest at
Dalhousie University. For this reason, we conducted a
sensitivity analysis with exclusion of the lower-response
rate sites.
All students participated in a mental health lecture
series and case discussions during their mental health
rotations. At Dalhousie the curriculum is problem based,
and for 5 weeks the focus is mental health and psycho-
tropic medications. At Memorial, the rotation involved
32 hours of instructional time, 18 hours of lecture and
12 hours of tutorials over approximately 4.5 weeks. The
Saskatchewan rotation consisted of 20 hours of lectures
and 2 ninety minute tutorials. No compensation was
provided to participants in the study. None of the rota-
tions involved clinical placements.Figure 1 Schematic of study procedures*. *CBE = Contact Based EducatThere were 84 students eligible to participate from
Dalhousie University, 86 from the University of
Saskatchewan, and 41 students from Memorial Univer-
sity. All students were asked to complete a baseline
questionnaire before their mental health rotation began.
Those randomly allocated to the “early group” com-
pleted the second questionnaire following their contact-
based education session. At the same time the “late
group” also completed this questionnaire but without
having yet experienced the contact-based education. The
study design was possible because of flexibility in the
curricula at these schools. While the early group was
doing their contact-based education sessions, the late
group was involved in other aspects of their curriculum,
and vice versa. The educational content did not differ
between the groups, only the order in which different
educational activities were delivered. Ethics approval for
the study was received from the Conjoint Health Re-
search Ethics Board at the University of Calgary, and
from Ethics Boards at each of the three sites. Data col-
lection occurred between September 2010 and May
2011.
Intervention: contact-based education
The contact-based education involved learning about
mental illness from people with first-hand experience.
Each of the contact-based sessions employed people
with lived experience, but who were in a state of recov-
ery. None of the sessions had a lecture format and all
were designed to foster interaction between the students
and the person with lived experience. In keeping
with this goal, all of the sessions were interactive. At
Dalhousie University, each of two 1 hour contact based-
educational sessions involved two young adults with a
diagnosis of bipolar disorder or schizophrenia. The early
and late sessions involved different people, due to limits
on availability, addressing approximately 42 students perion.
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testimonies) and answered student questions. Each ses-
sion was facilitated by the course professor and a staff
member of a local mental health support organization.
Questions of “have you ever experienced stigma in a
pharmacy?” and “what do you want from your pharma-
cist?” were addressed among other more personal ques-
tions about living with a mental illness.
At the University of Saskatchewan, the early and late
sessions were 90-minutes in duration and involved the
same three speakers to ensure consistency. Two speakers
indicated that their diagnoses were schizophrenia and
schizoaffective disorder. They were also in a state of re-
covery at the time of the presentation. They spoke about
their experience growing up with a mental illness and
their experiences with its management. The other
speaker was a mother of a young man with schizophre-
nia who spoke about what she and the family members
experienced in relation to her son’s mental illness. The
session was complemented by the input of a mental
health professional that provided an overview on schizo-
phrenia and its management.
Similarly, at Memorial, three members of the New-
foundland Chapter of the Schizophrenia Society (patient,
family member, and a health care provider) delivered a
two hour session on their experiences with this illness.
The sessions were facilitated by a course instructor and
included discussions about the types of interactions and
resultant impressions the guest speakers had formed
regarding their experiences with pharmacists.
Survey instrument
A 20-item questionnaire, the Opening Minds Survey for
Health Care Providers (OMS-HC), was the instrument
used to assess attitudes of pharmacy students toward
people with mental illness (Additional file 1). The OMS-
HC requires participants to respond to statements using
a 5-point Likert scale from “strongly agree” to “strongly
disagree”. Each item is scored 1–5, such that OMS-HC
scores range from 20 (minimal stigma) to 100 (max-
imum stigma). The OMS-HC was developed and vali-
dated in an earlier study [20]. Validation procedures
included the development, testing and refinement of an
item-pool, obtaining feedback from experts and focus
groups and psychometric evaluation. Psychometric ana-
lyses indicated that the OMS-HC scale can be scored
using a single total score, but that it encompasses five
stigma domains: social distance, disclosure, self-stigma,
prejudice and devaluation, and the social responsibility
and role of health care providers. The overall scores pro-
vide a global index of stigmatization. Its internal
consistency in the development phase was found to be
good (Cronbach’s alpha = 0.82) with satisfactory test-
retest reliability, intraclass correlation = 0.66 (95% CI0.54 to 0.75). The OMS-HC was only weakly correlated
with social desirability, indicating that the social desir-
ability bias was not likely to be a major determinant of
OMS-HC scores.
Some of the questions on the OMS-HC survey instru-
ment were adapted from existing scales and some were
original questions. Four questions were used from the
Mental Illness: Clinicians’ Attitudes (MICA) scale [21].
The MICA scale was developed for use with medical
students in England and has been shown to have satis-
factory validity and reliability. It is responsive to change
before and after stigma intervention. Several additional
items were used in the data collection as well, including
demographic information (age and gender) and an item
asking whether participants had a close friend or family
member with a mental illness. As social contact may di-
minish stigma, social contact occurring within family or
peer groups was a possible confounder. Demographic
variables needed to be measured as they also had the po-
tential to confound or modify the results.
Data analysis
The primary outcome variable was change in OMS-HC
score between baseline and the second survey (T1 to T2),
at which time only the early group had experienced the
contact-based education. Strictly speaking the primary
analysis was not based on intention to treat as it required
that there be two measures in order to be included. The
change scores were found to be approximately normally
distributed and had similar variance in the two groups.
All analyses used Stata [22]. Descriptive statistics were
calculated for demographic variables and baseline OMS-
HC scores. Prior to comparing the two groups, we used an
analysis of centre by group interactions to confirm that the
effects of the intervention were homogeneous across cen-
tres. Initially, change in OMS-HC scores were compared
using an independent samples t-test. The possibility of dif-
ferential intervention effects by age and gender were
explored using interaction terms. Effect sizes using Cohen’s
d approach were calculated for OMS-HC change scores.
In a secondary analysis we used a mixed-model to ad-
just confidence limits for possible correlations within
study sites and to incorporate the T3 data [22]. Two
observations (change from baseline to the second survey
and change from the second to the third survey) were
nested within each subject, and the subjects were nested
within their study centre. The success of the interven-
tion was assessed using the Wald test of interaction be-
tween group and interval (T1 to T2 and T2 to T3).
Results
Sample characteristics
Of the 211 (Dalhousie, n = 84; Saskatchewan, n = 86;
Memorial, n = 41) students eligible to participate in the
Patten et al. BMC Medical Education 2012, 12:120 Page 5 of 9
http://www.biomedcentral.com/1472-6920/12/120study, 131 completed a baseline survey (62.1% response
rate). Of these, 87 students completed the second survey
and 74 completed all three surveys yielding follow-up
rates of 66.4% (T2) and 56.5% (T3).
Baseline measures
The largest proportion of respondents completing the
baseline survey were from Dalhousie University (49.6%)
followed by the University of Saskatchewan (26.7%) and
Memorial University (23.7%). Participant characteristics
are summarized in Table 1. The two right-hand columns
of this table present frequencies among subjects with
complete data collection by the second (T2) and final
(T3) time points. The higher rate of successful follow-up
at Dalhousie was the only significant difference between
completers and non-completers, see Table 1.
The mean age of the respondents was 23.8 years
(standard deviation 2.6) and 73% of respondents were fe-
male. As seen in Table 2, there was no major difference
between early and late intervention groups, per
randomization. None of the baseline differences seen in
Table 2, were statistically significant (p-values not
shown, all > 0.05). Most respondents (85.4%) indicated
knowing a family member or close friend with a mental
illness.
Outcomes
The internal consistency of the OMS-HC in this sample,
measured using Cronbach’s alpha, was 0.84 at baseline,






Early 58 (44.3 %) 28 (49.1 %)
Late 73 (55.7 %) 29 (50.9 %)
School
Memorial 31 (23.7 %) 21 (36.8 %)
Saskatchewan 35 (26.7 %) 21 (36.8 %)
Dalhousie 65 (49.6 %) 15 (26.3 %)
Sex
Male 35 (26.7 %)
Female 96 (73.3 %)
Age, Mean (sd) 23.8 (2.6) 23.7 (1.9)
Close friend/ family with MI*
No 11 (8.9 %) 4 (7.3 %)
Yes 105 (85.4 %) 48 (87.3 %)
Don’t know 7 (5.7 %) 3 (5.5 %)
* Comparison of respondents with and without complete follow-up. Fisher’s exact t
of mean age.
** Not all participants responded to this item. MI: mental illness.homogeneity of the intervention effect across study sites
by assessing group by centre interaction. As there were
three sites, a likelihood ratio test was used to jointly as-
sess the two resulting interaction terms. This was non-
significant (p = 0.76), confirming the homogeneity and
justifying a pooling of the analysis across the three cen-
tres. At baseline, OMS-HC scale scores did not differ
significantly between early and late intervention groups
(mean scores 46.5 versus 47.8, t = −0.95, p<0.34). Table 3
shows participants’ OMS-HC scores stratified according
to intervention group. The T1 to T2 change was statisti-
cally significantly in the early group (mean change 4.3,
t=4.4, p <0.0001), but not in the late group (mean
change 1.5, t=1.7, p = 0.098), see Table 4. The T2 to T3
change was not significant in the early group (mean
change 0.77, t=0.94, p = 0.35) but was significant in the
late group (mean change 4.3, t=6.0, p < 0.0001). The dif-
ference in T1 to T2 change scores in the early versus the
late group was significant, such that the null hypothesis
associated with the primary analysis was rejected (mean
change 4.3 versus 1.5, t=2.1, p=0.04). The same result
was obtained when linear regression was used to assess
the group effect with inclusion of centre as a stratifica-
tion term (z = 0.197, p = 0.049). By the final assessment
(T3), at which point both groups had received the inter-
vention, scores were lower than baseline in each group
and were again comparable between groups. In the early
intervention group the difference between T1 and T3
was significant (mean change 3.6, t=3.6, p<0.001), as was









30 (45.5 %) 0.38 36 (41.4 %) 30 (45.5 %)
44 (59.5 %) 51 (58.6 %) 44 (59.5 %)
10 (13.5 %) P<0.001 13 (14.9 %) 10 (13.5 %)
14 (18.9 %) 18 (20.7 %) 14 (18.9 %)
50 (67.6 %) 56 (64.4 %) 50 (67.6 %)
0.55 21 (24.1 %) 18 (24.3%)
66 (75.9 %) 56 (75.7%)
24.0 (3.1) 0.53 23.9 (2.9) 24.0 (3.1)
7 (10.3 %) 0.93 9 (11.2 %) 7 (10.3 %)
57 (83.8 %) 67 (83.8 %) 57 (83.8 %)
4 (5.9 %) 4 (5.0 %) 4 (5.9 %)
est was used for categorical variables and a t-test was used in the comparison
Table 2 Description of respondents, by group
All respondents (n = 131) T1 to T2 (n = 87) T1 to T3 (n = 74)
early (n = 58) late (n = 73) early (n = 36) late (n = 51) early (n = 30) late (n = 44)
School
Memorial 13 (22.4 %) 18 (24.7 %) 3 (8.3 %) 10 (19.6 %) 2 (6.7 %) 8 (18.1 %)
Saskatchewan 16 (27.6 %) 19 (26.0 %) 8 (22.2 %) 10 (19.6 %) 6 (20.0 %) 8 (18.1 %)
Dalhousie 29 (50.0 %) 36 (49.3 %) 25 (69.4 %) 31 (60.8 %) 22 (73.3 %) 28 (63.6 %)
Sex
Male 16 (27.6 %) 19 (26.0 %) 8 (22.2 %) 13 (25.5 %) 7 (23.3 %) 11 (25.0 %)
Female 42 (72.4 %) 54 (74.0 %) 28 (77.8 %) 38 (75.5 %) 23 (76.7 %) 33 (75.0 %)
Age, mean (sd) 23.6 (1.7) 24.1 (3.3) 23.7 (2.0) 24.1 (3.4) 23.7 (2.0) 24.2 (3.6)
Close friend/family with MI**
No 6 (10.9 %) 5 (7.4 %) 6 (17.7 %) 3 (6.5 %) 5 (17.2 %) 2 (5.1 %)
Yes 43 (78.2 %) 62 (91.2 %) 24 (70.6 %) 43 (93.5 %) 20 (69.0 %) 37 (94.9 %)
Don’t know 6 (10.9 %) 1 (1.5 %) 4 (11.8 %) 0 (0 %) 4 (13.8 %) 0 (0 %)
* there were no significant differences between early and late groups. Fisher’s exact test was used for categorical variables and a t-test was used in the
comparison of mean age.
** totals for “no”, “yes” and “don’t know” responses do not sum to the column totals due to missing data on this item. MI: mental illness.
Table 4 Changes in unadjusted OMS-HC scores according
to group, sex, and school, by study interval
Mean Change (SD) Mean Change (SD) Mean Change (SD)
T1-T2 T2 -T3 T1-T3
n = 87 n=74 n=74
All participants
Early - 4.3 (6.0)* - 0.8 (4.5) - 4.4 (6.0)*
Late - 1.5 (6.4) - 4.3 (4.7)* - 5.3 (6.7)*
Female
Early - 4.4 (5.7)* - 1.0 (4.6) - 4.7 (5.3)*
Late - 2.2 (6.0) - 4.3 (4.9)* - 5.7 (6.7)*
Male
Early - 4.1 (7.3) - 0.1 (4.3) - 3.4 (8.4)
Late + 0.6 (7.2) - 4.4 (4.3)* - 4.0 (6.6)
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early (mean score 42.6) versus late (mean score 43.1)
groups was not significant, t = −0.25, p=0.80.
Table 4 shows change in OMS-HC scores stratified by
group, gender, and school over the course of the study.
Upon receiving the contact based intervention (T1 to T2
for the early group and T2 to T3 for the late group),
there was a similar reduction in OMS-HC scores in men
and women and in the different settings.
The mixed model regression analysis was initially
restricted to people with complete follow-up at all three
time points (n=74) and included time interval (T1 to T2
versus T2 to T3), early versus late group, and indicator
variables for the different universities. A likelihood ratio
test again identified no group by centre interactions
(p=0.85), justifying pooling across all three sites. The ef-
fect of contact-based education was assessed as a group
by time interaction, which was highly significant,
p<0.0001. The effect remained significant when covari-
ates were added to the model (age, sex, and close rela-
tionship with someone with a mental illness) and with




n Score (95% CI) n Score (95% CI)
T1 131 58 46.7 (44.5-48.4) 73 47.8 (45.8-49.9)
T2 87 36 43.6 (40.9-46.4) 51 46.8 (44.8-48.9)
T3 74 30 42.6 (39.8-45.4) 44 43.1 (40.6-45.5)
*The difference between T1 and T2 was statistically significant for the Early
group as was the difference between T2 and T3 for the Late group. T1 to T3
differences were significant in both groups, see Table 4.mixed model can accommodate missing data under the
missing at random assumption.
A separate analysis using only the Dalhousie data
showed group differences from baseline to post-Memorial
Early - 3.3 (7.7) - 1.5 (6.4) - 9.0 (9.9) *
Late - 0.7 (6.2) - 4.4 (5.0)* - 5.8 (9.8) *
Saskatchewan
Early - 4.8 (3.5)* + 0.2 (2.1) - 3.7 (2.2)*
Late - 3.9 (7.1) - 2.6 (3.9) - 6.3 (8.8)
Dalhousie
Early - 4.3 (6.5)* −1.0 (4.9) - 4.2 (6.5)*
Late - 1.0 (6.2) - 4.8 (4.9)* - 4.9 (5.0)*
*Statistically significant, based on one-sample t-tests (where Ho: change = 0
and α = 0.05).
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p=0.06) and baseline to one-month post-course (T1 to
T3) (mean change 4.5, t=5.3, p<0.0001), consistent with
the results of the multi-centre analysis.
Effect size
Based on the unadjusted data provided in Tables 3 and
4, the contact-based education effect sizes were esti-
mated based on change scores. The effect size associated
with the first contact based education session was 0.45.
Translated, this effect size indicates that 68% of phar-
macy students that participated in the education session
had a greater improvement in their OMS-HC scores
than the average student who did not participate in the
session. For the second contact based education session
the impact was greater. The effect size was 0.77, indicat-
ing that 78% of those who received the education inter-
vention had a greater change in their OMS-HC scores
compared to the average score change in the other
group.
Discussion
Our study showed that mental health courses for phar-
macy students using contact-based sessions reduced
mental health-related stigma among pharmacy students
at three pharmacy faculties in Canada. We believe this
to be the first randomized study to show that such ses-
sions diminish stigma among pharmacy students.
A minor and non-significant change in OMS-HC
scores during the regular mental health education ses-
sions and a substantial change following contact-based
education sessions suggest that this intervention has a
more substantial effect on reducing stigma than did
regular undergraduate teaching methods. At Dalhousie
University, which has a problem-based learning curricu-
lum, the first issue brought up in the first case of the
mental health module directly highlighted pharmacist-
based stigmatization of an individual with schizophrenia.
Each small learning group discussed this issue and was
facilitated by in-room tutors. A complementary lecture
discussed stigma and guided students to videos that are
intended to promote their understanding of stigma from
the patient’s perspective. What these cases, lectures, and
videos lack is an interactive, social component that dir-
ectly involves a person affected by mental illness. The
results of this study point towards the added effective-
ness of this kind of contact.
A previous meta-analysis examined three mediators of
the effect of social contact on prejudice (a concept
related to stigmatization): knowledge, anxiety reduction
and empathy [23]. All three appeared to act as media-
tors, but knowledge had the weakest effect. Curricula
that supplement their knowledge-based components
with social contact may make more pronounced gainsthrough mechanisms such as diminished anxiety and
increased empathy. Allport’s optimal conditions for the
effectiveness of contact in reducing prejudice, as sum-
marized by Pettigrew and Topp [24] include: equal sta-
tus between the groups; common goals; intergroup
cooperation; and the support of authorities, law, or cus-
tom. Within this framework, it is not surprising that
traditional rotations do not seem to robustly reduce
aspects of stigma such as social distance [15]. Contact-
based sessions involve social interaction characterized by
greater equality than sometimes characterizes relation-
ships between professional-providers and service-users.
One of the reasons for why contact-based sessions may
be more effective is that they established more equal sta-
tus. Studies that have used consumer-educators (e.g.
[16]) also establish greater equality and may reduce so-
cial distance as a result.
Our study had several limitations. Response rates to
the baseline survey were lower at the University of
Saskatchewan (40.7%) compared to the other two
schools (Memorial University, 75.6%; Dalhousie
University, 77.4%). The highest number of dropouts
came from Memorial University and the University of
Saskatchewan. Attrition can be a source of bias in
this type of study. The rate of successful follow-up
for the individual schools was 32.3% (Memorial),
40.0% (Saskatchewan), and 76.9% (Dalhousie). A sen-
sitivity analysis that examined the primary outcome
using only students from Dalhousie, however, found
similar results. The low overall response rate may,
however, diminish the generalizability of the results.
For ethical reasons, we were not able to compare stu-
dents choosing, or not, to participate in the study.
The OMS-HC is a new tool specifically designed to
measure the attitudes of health care providers to-
wards the mentally ill. Therefore it is not yet possible
to compare the effects seen in this study with those
of other interventions in other populations. Another
limitation is that whereas the T2 assessment occurred
within a few days of the contact-based education ses-
sion for the early group, the final assessment oc-
curred one month after the late group’s session. A
greater effect might have been expected in the early
group because of this. However, this issue appears not
to be a major one since the improvement between T2
and T3 in the late group was similar to that between
T1 and T2 in the early group. As the students that
had their contact-based education session would have
interacted with those that had not yet participated
there is the possibility that communication might
have cross-contaminated the groups. If such contact
had improved the attitudes of the late group at T2 it
might have diluted the apparent effect of the
intervention. Such cross-contamination could have
Patten et al. BMC Medical Education 2012, 12:120 Page 8 of 9
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ish the credibility of the positive result that was
observed in this study.
Another limitation relates to the use of an attitude
scale to assess outcome. Ideally, interventions would be
assessed at the level of behaviour rather than attitudes.
Although OMS-HC ratings have been shown to be dis-
tinct from social desirability ratings [20], it is always pos-
sible that attitude scales are influenced by social
desirability bias.
Contact-based education appears to be effective at re-
ducing mental health related stigma in pharmacy stu-
dents and findings from this study support the inclusion
of this type of education in the mental health modules
of pharmacy schools. Qualitative [25], uncontrolled [26]
and controlled but non-randomized [16,27] interven-
tions involving people with mental illnesses participating
in pharmacy education have reported generally positive
results on social distance and items assessing stigmatiz-
ing attitudes. The current study adds to this literature
through its use of randomization, providing more robust
evidence that the contact-based component is an active
ingredient of stigma reduction.
This study was short-term. Future research should
seek to determine if the effects are long lasting and, if
necessary, to identify ways of maintaining or boosting
the benefits over the long term. However, one prior
study found that effects from a consumer-led interven-
tion were sustained for one year [26], suggesting that
such effects are not transient effects. While this study
focussed on students, the population of practicing phar-
macists may also be able to benefit from this type of
intervention. However, the generalizability of these
results to that population, or to other health professions,
cannot be assumed. Furthermore, generalizability to
other groups of pharmacy students and other pharmacy
schools needs to be confirmed by replication of these
results.
Conclusions
Contact-based education is an effective anti-stigma
intervention when incorporated into pharmacy curricula.
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